BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8932851)

  • 21. Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
    Nadar SK; Al Yemeni E; Blann AD; Lip GY
    Thromb Res; 2004; 113(2):123-8. PubMed ID: 15115667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of von Willebrand factor, soluble thrombomodulin, and soluble p-selectin during orthotopic liver transplantation.
    Wang YI; Li G; Zhang Y; Gao W; Yao Z
    Transplant Proc; 2007; 39(1):172-5. PubMed ID: 17275499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
    Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial function and novel adhesion molecule CD44 in kidney allograft recipients.
    Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
    Transplant Proc; 2008 Dec; 40(10):3470-3. PubMed ID: 19100415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma thrombomodulin in orthotopic liver transplantation.
    Boutiere B; Arnoux D; Boffa MC; Samson D; Le Treut YP; Sampol J
    Transplantation; 1994 Dec; 58(12):1352-5. PubMed ID: 7809928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
    Lee KW; Blann AD; Lip GY
    Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of standard anthracycline-based chemotherapy on soluble ICAM-1 and vascular endothelial growth factor levels in breast cancer.
    Mills PJ; Parker B; Jones V; Adler KA; Perez CJ; Johnson S; Cohen-Zion M; Marler M; Sadler GR; Dimsdale JE; Ancoli-Israel S
    Clin Cancer Res; 2004 Aug; 10(15):4998-5003. PubMed ID: 15297400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical markers of endothelial activation in primary hyperparathyroidism.
    Fallo F; Cella G; Casonato A; Ermani M; Vettor R; Zanella S; Lumachi F
    Horm Metab Res; 2006 Feb; 38(2):125-9. PubMed ID: 16523414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma concentrations of von Willebrand factor and intracellular adhesion molecule-1 for prediction of outcome after successful cardiopulmonary resuscitation.
    Geppert A; Zorn G; Delle-Karth G; Koreny M; Siostrzonek P; Heinz G; Huber K
    Crit Care Med; 2003 Mar; 31(3):805-11. PubMed ID: 12626988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation.
    Gando S; Kameue T; Matsuda N; Hayakawa M; Hoshino H; Kato H
    Thromb Res; 2005; 116(2):91-100. PubMed ID: 15907522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Laboratory indicators of endothelial involvement in rheumatic diseases associated with vasculitis in children].
    Dolezalová P; Telekesová P; Nĕmcová D; Bĕlorová J; Kvasnicka J; Hoza J
    Cas Lek Cesk; 2003; 142(10):615-9. PubMed ID: 14635427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of puerarin with aspirin on the markers of damaged vascular endothelial cells in patients with acute cerebral infarction].
    Hu HT; Fen F; Ding MP
    Zhongguo Zhong Yao Za Zhi; 2008 Dec; 33(23):2827-9. PubMed ID: 19260323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measures of endothelial dysfunction in plasma of patients with posttraumatic stress disorder.
    von Känel R; Hepp U; Traber R; Kraemer B; Mica L; Keel M; Mausbach BT; Schnyder U
    Psychiatry Res; 2008 Apr; 158(3):363-73. PubMed ID: 18252265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Values of soluble thrombomodulin and von Willebrand factor judging reject reaction in liver transplantation].
    Wen CG; Luo SK; He XS; Li J; Liu M; Zou WY; Peng AH
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):295-7. PubMed ID: 12773246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term high-dose folic acid does not alter markers of endothelial cell damage in patients with coronary heart disease.
    Doshi SN; Moat SJ; Lewis MJ; McDowell IF; Giddings JC; Goodfellow J
    Int J Cardiol; 2004 Apr; 94(2-3):203-7. PubMed ID: 15093982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
    Gardinali M; Pozzi MR; Bernareggi M; Montani N; Allevi E; Catena L; Cugno M; Bottasso B; Stabilini R
    J Rheumatol; 2001 Apr; 28(4):786-94. PubMed ID: 11327251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction.
    Freestone B; Chong AY; Blann AD; Lip GY
    Thromb Res; 2006; 118(4):479-85. PubMed ID: 16318868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased serum levels of circulating intercellular adhesion molecule 1 predict the risk of graft rejection after bone marrow transplantation for thalassemia.
    Centis F; Delfini C; Annibali M; Galimberti M; Agostinelli F; Nicolini G; Lucarelli G
    Bone Marrow Transplant; 1997 Jul; 20(2):125-8. PubMed ID: 9244415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.